Trial · NCT03802838
Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
NCT03802838, Phase 4, Unknown, Shanghai Mental Health Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia. Trials, record NCT03802838. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03802838
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
- NCT number
- NCT03802838
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Shanghai Mental Health Center
- Conditions
- Schizophrenia
- Interventions
- acupuncture, Amisulpride
- First posted
- 2019-01-14
- Last updated
- 2019-01-14
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Positive and Negative Syndrome Scale (PANSS) | the baseline | a 30-items, 7-point rating scale; the 7 rating points represent increasing levels of psychopathology: 1= absent, 2= minimal, 3= mild, 4 = moderate, 5= moderate-severe, 6= severe, 7= extreme; of the 16 items, 7 were chosen to constitute Positive Scale, 7 items for Negative Scale and the remaining 16 items for a General Psychopathology Scale |
| Primary | The Positive and Negative Syndrome Scale (PANSS) | the end of 12 weeks | a 30-items, 7-point rating scale; the 7 rating points represent increasing levels of psychopathology: 1= absent, 2= minimal, 3= mild, 4 = moderate, 5= moderate-severe, 6= severe, 7= extreme; of the 16 items, 7 were chosen to constitute Positive Scale, 7 items for Negative Scale and the remaining 16 items for a General Psychopathology Scale |
| Primary | The Clinical Assessment Interview for Negative Symptoms (CAINS) | the baseline | including CAINS and CAINS self-reported checklists |
| Primary | The Clinical Assessment Interview for Negative Symptoms (CAINS) | the end of 12 weeks | including CAINS self-reported checklists |
| Primary | Repeatable sets of neuropsychological state measurements (RBANS) | the baseline | That allows us to measure cognitive impairment in patients. |
| Primary | Repeatable sets of neuropsychological state measurements (RBANS) | the end of 12 weeks | That allows us to measure cognitive impairment in patients. |
| Secondary | The Temporal Experience of Pleasure Scale (TEPS) | the baseline | That allows us to measure the experience of pleasure in patients. |
| Secondary | The Temporal Experience of Pleasure Scale (TEPS) | the end of 12 weeks | That allows us to measure the change of experience of pleasure in patients. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03802838
GET https://conductscience.org/api/trials/v1/NCT03802838/registered